384 filings
DEFA14A
ALKS
Alkermes plc
14 May 24
Additional proxy soliciting materials
4:30pm
10-Q
2024 Q1
ALKS
Alkermes plc
Quarterly report
1 May 24
5:14pm
8-K
ALKS
Alkermes plc
1 May 24
Alkermes plc Reports First Quarter 2024 Financial Results
7:05am
ARS
2023 FY
ALKS
Alkermes plc
15 Apr 24
Annual report to shareholders
4:27pm
DEFA14A
ALKS
Alkermes plc
15 Apr 24
Additional proxy soliciting materials
4:23pm
8-K
3b10wiglt69f3kp4
9 Apr 24
Regulation FD Disclosure
7:09am
8-K
9xzog9vvd1
7 Mar 24
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
7:09am
8-K
ygp7q2
15 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
07sv8ql mswrys
5 Feb 24
Departure of Directors or Certain Officers
4:29pm
8-K
482r3b
8 Jan 24
Regulation FD Disclosure
7:00am
8-K
k2exu7czol3z
14 Dec 23
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
6:13am
8-K
0vokvx1g0v459kd1r3
8 Dec 23
Departure of Directors or Certain Officers
4:05pm
8-K
vklpfo
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
rsqjiq0t3n3e4cw
31 Oct 23
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
5:18pm
8-K
r7ohvwdj3
27 Oct 23
Other Events
5:12pm
8-K
rzjk0odcs3
25 Oct 23
Alkermes plc Reports Third Quarter 2023 Financial Results
7:06am